Global Plasma-derived Immune Inhibitors Sales Market Report 2021

August 2016 | 103 pages | ID: G0716F72610EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Plasma-derived Immune Inhibitors

Revenue, means the sales value of Plasma-derived Immune Inhibitors


This report studies sales (consumption) of Plasma-derived Immune Inhibitors in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Amgen
• AstraZeneca
• Baxter
• Britannia
• Capricor
• CSL Behring
• GlaxoSmithKline
• Grifols
• Ferring
• Janssen
• NeuroDerm
• Octapharma
• Roche
• Rhythm Metabolic
• scPharmceuticals
• SteadyMed
• Takeda
• United Therapeutics
• UCB
• US Worldmeds

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Plasma-derived Immune Inhibitors in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Plasma-derived Immune Inhibitors in each application, can be divided into

• Medical care
• Hospital
• Application 3

Contents

Global Plasma-derived Immune Inhibitors Sales Market Report 2021

1 PLASMA-DERIVED IMMUNE INHIBITORS OVERVIEW

1.1 Product Overview and Scope of Plasma-derived Immune Inhibitors
1.2 Classification of Plasma-derived Immune Inhibitors
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Plasma-derived Immune Inhibitors
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 Plasma-derived Immune Inhibitors Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Plasma-derived Immune Inhibitors (2011-2021)
  1.5.1 Global Plasma-derived Immune Inhibitors Sales, Revenue and Price (2011-2021)
  1.5.2 Global Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
  1.5.3 Global Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)

2 GLOBAL PLASMA-DERIVED IMMUNE INHIBITORS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Plasma-derived Immune Inhibitors Market Competition by Manufacturers
  2.1.1 Global Plasma-derived Immune Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Plasma-derived Immune Inhibitors Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Plasma-derived Immune Inhibitors (Volume and Value) by Type
  2.2.1 Global Plasma-derived Immune Inhibitors Sales and Market Share by Type (2011-2021)
  2.2.2 Global Plasma-derived Immune Inhibitors Revenue and Market Share by Type (2011-2021)
2.3 Global Plasma-derived Immune Inhibitors (Volume and Value) by Regions
  2.3.1 Global Plasma-derived Immune Inhibitors Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Plasma-derived Immune Inhibitors Revenue and Market Share by Regions (2011-2021)
2.4 Global Plasma-derived Immune Inhibitors (Volume) by Application

3 NORTH AMERICA PLASMA-DERIVED IMMUNE INHIBITORS (VOLUME, VALUE AND SALES PRICE

3.1 North America Plasma-derived Immune Inhibitors Sales and Value (2011-2021)
  3.1.1 North America Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
  3.1.2 North America Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
  3.1.3 North America Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
3.2 North America Plasma-derived Immune Inhibitors Sales and Market Share by Manufacturers
3.3 North America Plasma-derived Immune Inhibitors Sales and Market Share by Type
3.4 North America Plasma-derived Immune Inhibitors Sales and Market Share by Applications

4 CHINA PLASMA-DERIVED IMMUNE INHIBITORS (VOLUME, VALUE AND SALES PRICE

4.1 China Plasma-derived Immune Inhibitors Sales and Value (2011-2021)
  4.1.1 China Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
  4.1.2 China Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
  4.1.3 China Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
4.2 China Plasma-derived Immune Inhibitors Sales and Market Share by Manufacturers
4.3 China Plasma-derived Immune Inhibitors Sales and Market Share by Type
4.4 China Plasma-derived Immune Inhibitors Sales and Market Share by Applications

5 EUROPE PLASMA-DERIVED IMMUNE INHIBITORS (VOLUME, VALUE AND SALES PRICE

5.1 Europe Plasma-derived Immune Inhibitors Sales and Value (2011-2021)
  5.1.1 Europe Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
  5.1.2 Europe Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
5.2 Europe Plasma-derived Immune Inhibitors Sales and Market Share by Manufacturers
5.3 Europe Plasma-derived Immune Inhibitors Sales and Market Share by Type
5.4 Europe Plasma-derived Immune Inhibitors Sales and Market Share by Applications

6 JAPAN PLASMA-DERIVED IMMUNE INHIBITORS (VOLUME, VALUE AND SALES PRICE

6.1 Japan Plasma-derived Immune Inhibitors Sales and Value (2011-2021)
  6.1.1 Japan Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
  6.1.2 Japan Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
6.2 Japan Plasma-derived Immune Inhibitors Sales and Market Share by Manufacturers
6.3 Japan Plasma-derived Immune Inhibitors Sales and Market Share by Type
6.4 Japan Plasma-derived Immune Inhibitors Sales and Market Share by Applications

7 SOUTHEAST ASIA PLASMA-DERIVED IMMUNE INHIBITORS (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Plasma-derived Immune Inhibitors Sales and Value (2011-2021)
  7.1.1 Southeast Asia Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
7.2 Southeast Asia Plasma-derived Immune Inhibitors Sales and Market Share by Manufacturers
7.3 Southeast Asia Plasma-derived Immune Inhibitors Sales and Market Share by Type
7.4 Southeast Asia Plasma-derived Immune Inhibitors Sales and Market Share by Applications

8 INDIA PLASMA-DERIVED IMMUNE INHIBITORS (VOLUME, VALUE AND SALES PRICE

8.1 India Plasma-derived Immune Inhibitors Sales and Value (2011-2021)
  8.1.1 India Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
  8.1.2 India Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
  8.1.3 India Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
8.2 India Plasma-derived Immune Inhibitors Sales and Market Share by Manufacturers
8.3 India Plasma-derived Immune Inhibitors Sales and Market Share by Type
8.4 India Plasma-derived Immune Inhibitors Sales and Market Share by Applications

9 GLOBAL PLASMA-DERIVED IMMUNE INHIBITORS MANUFACTURERS ANALYSIS

9.1 Amgen
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2016)
9.2 AstraZeneca
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Baxter
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2016)
9.4 Britannia
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Capricor
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2016)
9.6 CSL Behring
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2016)
9.7 GlaxoSmithKline
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2017)
9.8 Grifols
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Ferring
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Janssen
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Plasma-derived Immune Inhibitors Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Plasma-derived Immune Inhibitors Sales, Revenue, Price of Company One (2015 and 2021)
9.11 NeuroDerm
9.12 Octapharma
9.13 Roche
9.14 Rhythm Metabolic
9.15 scPharmceuticals
9.16 SteadyMed
9.17 Takeda
9.18 United Therapeutics
9.19 UCB
9.20 US Worldmeds

10 PLASMA-DERIVED IMMUNE INHIBITORS TECHNOLOGY AND DEVELOPMENT TREND

10.1 Plasma-derived Immune Inhibitors Technology Analysis
10.2 Plasma-derived Immune Inhibitors Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Plasma-derived Immune Inhibitors
Table Classification of Plasma-derived Immune Inhibitors
Figure Global Sales Market Share of Plasma-derived Immune Inhibitors by Type in 2015
Table Applications of Plasma-derived Immune Inhibitors
Figure Global Sales Market Share of Plasma-derived Immune Inhibitors by Applications in 2015
Figure Medical care Examples
Figure Hospital Examples
Figure North America Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure China Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure Europe Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure Japan Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure India Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Table Global Plasma-derived Immune Inhibitors Sales, Revenue and Price (2011-2021)
Figure Global Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
Figure Global Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Table Global Plasma-derived Immune Inhibitors Sales of Key Manufacturers (2015 and 2016)
Table Global Plasma-derived Immune Inhibitors Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Plasma-derived Immune Inhibitors Sales Share by Manufacturers
Figure 2016 Plasma-derived Immune Inhibitors Sales Share by Manufacturers
Table Global Plasma-derived Immune Inhibitors Revenue by Manufacturers (2015 and 2016)
Table Global Plasma-derived Immune Inhibitors Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Plasma-derived Immune Inhibitors Revenue Share by Manufacturers
Table 2016 Global Plasma-derived Immune Inhibitors Revenue Share by Manufacturers
Table Global Plasma-derived Immune Inhibitors Sales and Market Share by Type (2011-2021)
Table Global Plasma-derived Immune Inhibitors Sales Share by Type (2011-2021)
Figure Sales Market Share of Plasma-derived Immune Inhibitors by Type (2011-2021)
Figure Global Plasma-derived Immune Inhibitors Sales Growth Rate by Type (2011-2021)
Table Global Plasma-derived Immune Inhibitors Revenue and Market Share by Type (2011-2021)
Table Global Plasma-derived Immune Inhibitors Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Plasma-derived Immune Inhibitors by Type (2011-2021)
Figure Global Plasma-derived Immune Inhibitors Revenue Growth Rate by Type (2011-2021)
Table Global Plasma-derived Immune Inhibitors Sales and Market Share by Regions (2011-2021)
Table Global Plasma-derived Immune Inhibitors Sales Share by Regions (2011-2021)
Figure Sales Market Share of Plasma-derived Immune Inhibitors by Regions (2011-2021)
Figure Global Plasma-derived Immune Inhibitors Sales Growth Rate by Regions (2011-2021)
Table Global Plasma-derived Immune Inhibitors Revenue and Market Share by Regions (2011-2021)
Table Global Plasma-derived Immune Inhibitors Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Plasma-derived Immune Inhibitors by Regions (2011-2021)
Figure Global Plasma-derived Immune Inhibitors Revenue Growth Rate by Regions (2011-2021)
Table Global Plasma-derived Immune Inhibitors Sales and Market Share by Application (2011-2021)
Table Global Plasma-derived Immune Inhibitors Sales Share by Application (2011-2021)
Figure Sales Market Share of Plasma-derived Immune Inhibitors by Application (2011-2021)
Figure Global Plasma-derived Immune Inhibitors Sales Growth Rate by Application (2011-2021)
Figure North America Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
Figure North America Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure North America Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
Table North America Plasma-derived Immune Inhibitors Sales by Manufacturers (2015 and 2016)
Table North America Plasma-derived Immune Inhibitors Market Share by Manufacturers (2015 and 2016)
Table North America Plasma-derived Immune Inhibitors Sales by Type (2015 and 2016)
Table North America Plasma-derived Immune Inhibitors Market Share by Type (2015 and 2016)
Table North America Plasma-derived Immune Inhibitors Sales by Applications (2015 and 2016)
Table North America Plasma-derived Immune Inhibitors Market Share by Applications (2015 and 2016)
Figure Europe Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
Figure Europe Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure Europe Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
Table Europe Plasma-derived Immune Inhibitors Sales by Manufacturers (2015 and 2016)
Table Europe Plasma-derived Immune Inhibitors Market Share by Manufacturers (2015 and 2016)
Table Europe Plasma-derived Immune Inhibitors Sales by Type (2015 and 2016)
Table Europe Plasma-derived Immune Inhibitors Market Share by Type (2015 and 2016)
Table Europe Plasma-derived Immune Inhibitors Sales by Applications (2015 and 2016)
Table Europe Plasma-derived Immune Inhibitors Market Share by Applications (2015 and 2016)
Figure China Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
Figure China Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure China Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
Table China Plasma-derived Immune Inhibitors Sales by Manufacturers (2015 and 2016)
Table China Plasma-derived Immune Inhibitors Market Share by Manufacturers (2015 and 2016)
Table China Plasma-derived Immune Inhibitors Sales by Type (2015 and 2016)
Table China Plasma-derived Immune Inhibitors Market Share by Type (2015 and 2016)
Table China Plasma-derived Immune Inhibitors Sales by Applications (2015 and 2016)
Table China Plasma-derived Immune Inhibitors Market Share by Applications (2015 and 2016)
Figure Japan Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
Figure Japan Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure Japan Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
Table Japan Plasma-derived Immune Inhibitors Sales by Manufacturers (2015 and 2016)
Table Japan Plasma-derived Immune Inhibitors Market Share by Manufacturers (2015 and 2016)
Table Japan Plasma-derived Immune Inhibitors Sales by Type (2015 and 2016)
Table Japan Plasma-derived Immune Inhibitors Market Share by Type (2015 and 2016)
Table Japan Plasma-derived Immune Inhibitors Sales by Applications (2015 and 2016)
Table Japan Plasma-derived Immune Inhibitors Market Share by Applications (2015 and 2016)
Figure India Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
Figure India Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure India Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
Table India Plasma-derived Immune Inhibitors Sales by Manufacturers (2015 and 2016)
Table India Plasma-derived Immune Inhibitors Market Share by Manufacturers (2015 and 2016)
Table India Plasma-derived Immune Inhibitors Sales by Type (2015 and 2016)
Table India Plasma-derived Immune Inhibitors Market Share by Type (2015 and 2016)
Table India Plasma-derived Immune Inhibitors Sales by Applications (2015 and 2016)
Table India Plasma-derived Immune Inhibitors Market Share by Applications (2015 and 2016)
Figure Southeast Asia Plasma-derived Immune Inhibitors Sales and Growth Rate (2011-2021)
Figure Southeast Asia Plasma-derived Immune Inhibitors Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Plasma-derived Immune Inhibitors Sales Price Trend (2011-2021)
Table Southeast Asia Plasma-derived Immune Inhibitors Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Plasma-derived Immune Inhibitors Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Plasma-derived Immune Inhibitors Sales by Type (2015 and 2016)
Table Southeast Asia Plasma-derived Immune Inhibitors Market Share by Type (2015 and 2016)
Table Southeast Asia Plasma-derived Immune Inhibitors Sales by Applications (2015 and 2016)
Table Southeast Asia Plasma-derived Immune Inhibitors Market Share by Applications (2015 and 2016)
Table Amgen Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Plasma-derived Immune Inhibitors Sales, Revenue, Price of US Worldmeds (2015 and 2016)